John Mascarenhas - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

More than 200,000 flee France and Spain fires during extreme European heat

Care Career buys MAS Medical Staffing to expand healthcare workforce platform

China uses water cannon against Philippine vessels for second day near Scarborough Shoal

Energy Action reports A$12.2m FY2026 revenue as higher costs pressure earnings

Representative image of a laboratory research setting used to illustrate Karyopharm Therapeutics Inc.’s Phase 3 SENTRY trial in myelofibrosis and its late-breaking ASCO 2026 presentation.

Read More

Pharma Industry News

Karyopharm Therapeutics (KPTI) tees up ASCO 2026 readout as SENTRY trial shifts myelofibrosis debate

Karyopharm is taking its Phase 3 SENTRY myelofibrosis data to ASCO 2026. Read why the late-breaking slot matters for KPTI and selinexor now.

April 21, 2026

web analytics